Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Yarrow Bioscience, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +3 vs. Q3 2024
- Shares held
- 7.06M
- +412.1K (+6.2%) vs. Q3 2024
- Total value
- $23.4M
- +$10.4M (+80.1%) vs. Q3 2024
- New holders
- 9
- 10 more added
- Sold out
- 6
- 6 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 1,394,336 | $4.67M | 0.26% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 1,394,336 | $4.45M | 0.08% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,230,457 | $4.12M | 0.00% | +43,044+3.6% | Added |
| Vanguard Group Inc | 475,129 | $1.59M | 0.00% | +31,611+7.1% | Added |
| Acorn Capital Advisors, LLC | 456,970 | $1.53M | 0.82% | +456,970 | New |
| Palo Alto Investors LP | 445,434 | $1.49M | 0.23% | 00.0% | Unchanged |
| Exome Asset Management LLC | 353,434 | $1.18M | 0.89% | 00.0% | Unchanged |
| UBS Oconnor LLC | 245,800 | $823.4K | 0.02% | +245,800 | New |
| Schonfeld Strategic Advisors LLC | 176,658 | $591.8K | 0.00% | +8,058+4.8% | Added |
| Adage Capital Partners GP, L.L.C. | 154,134 | $516.3K | 0.00% | +154,134 | New |
| Parkman Healthcare Partners LLC | 152,973 | $512.5K | 0.07% | −50,000−24.6% | Reduced |
| Geode Capital Management, LLC | 135,017 | $452.3K | 0.00% | +427+0.3% | Added |
| BlackRock, Inc. | 83,314 | $279.1K | 0.00% | +245+0.3% | Added |
| Susquehanna International Group, LLP | 70,832 | $237.3K | 0.00% | +10,476+17.4% | Added |
| Prelude Capital Management, LLC | 59,400 | $199.0K | 0.02% | −5,747−8.8% | Reduced |
| Bridgeway Capital Management, LLC | 36,958 | $123.8K | 0.00% | +36,958 | New |
| Staley Capital Advisers Inc | 36,472 | $122.2K | 0.01% | 00.0% | Unchanged |
| Royal Bank of Canada | 25,229 | $84.0K | 0.00% | +22,789+934.0% | Added |
| Renaissance Technologies LLC | 24,943 | $83.6K | 0.00% | −61,700−71.2% | Reduced |
| Northern Trust Corp | 23,971 | $80.3K | 0.00% | −13,319−35.7% | Reduced |
| XTX Topco Ltd | 21,018 | $70.4K | 0.01% | +21,018 | New |
| Jane Street Group, LLC | 20,286 | $68.0K | 0.00% | +20,286 | New |
| Commonwealth Equity Services, LLC | 18,298 | $61.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 15,765 | $52.8K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 4,299 | $14.4K | 0.00% | +2,500+139.0% | Added |
| BFSG, LLC | 3,500 | $11.7K | 0.00% | +3,500 | New |
| Bank of America Corp | 1,491 | $5.00K | 0.00% | −787−34.5% | Reduced |
| Tower Research Capital LLC (TRC) | 1,386 | $4.64K | 0.00% | −823−37.3% | Reduced |
| MB, Levis & Associates, LLC | 1,041 | $3.49K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 631 | $2.11K | 0.00% | +617+4,407.1% | Added |
| CWM, LLC | 500 | $2.00K | 0.00% | +500 | New |
| JPMorgan Chase & Co | 314 | $1.05K | 0.00% | +137+77.4% | Added |
| Centerpoint Advisors, LLC | 350 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 65 | $218 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 5 | $17 | 0.00% | +5 | New |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −268,485−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −152,865−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −76,784−100.0% | Sold out |
| Lynx1 Capital Management LP | 0 | $0 | 0.00% | −16,194−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −187−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| DSC Advisors, L.P. | – | – | – | – | Not filed |